Senate Majority Leader Chuck Schumer (D-NY) is highlighting marijuana banking reform is one of several key legislative priorities that he intends to push through using bipartisan cooperation when the Senate reconvenes next month. The Republican sponsor of the cannabis bill, meanwhile, says this is the “best” time to get... Read more

A California Assembly committee has approved a Senate-passed bill to legalize the possession and facilitated use of certain psychedelics. The Assembly Public Safety Committee advanced the legislation from Sen. Scott Wiener (D) in a 5-2 vote, with amendments, on Tuesday—about one month after it was approved by the full... Read more

A newly formed coalition of marijuana businesses and advocacy organizations is making the case that the Biden administration really only has two viable choices when it comes to its ongoing federal scheduling review: remove cannabis from the list of banned substances altogether or reschedule it—the less ideal option of... Read more

Minnesota’s Supreme Court is looking for a designee to sit on a marijuana expungements board that is being created under the state’s new legalization law. In a public notice that was posted on Wednesday, the court described the composition and responsibilities of the Cannabis Expungement Board, which will facilitate... Read more

2024 Democratic presidential candidate Robert F. Kennedy Jr. took a swing at rival GOP contender Florida Gov. Ron DeSantis (R) on Sunday over his opposition to marijuana decriminalization—and he pledged to enact federal cannabis reform if elected. He did, however, decline an offer to smoke a joint with comedian... Read more

Florida Gov. Ron DeSantis (R), a 2024 GOP presidential candidate, said he would not federally decriminalize marijuana if elected to the White House—arguing that cannabis use hurts the workforce, inhibits productivity and could even lead to death if contaminated. At a campaign event in South Carolina on Thursday, a... Read more

The Food and Drug Administration (FDA) has released first-of-its-kind draft guidance on the “unique” considerations that researchers should take into account when studying psychedelics, which the agency says show “initial promise” as potential therapies. Two days after bipartisan congressional lawmakers filed a bill to direct the issuance of such... Read more